Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 59.50
Change Today 0.00 / 0.00%
Volume 0.0
INTP On Other Exchanges
Symbol
Exchange
OTC US
Tel Aviv
As of 11:24 AM 03/26/15 All times are local (Market data is delayed by at least 15 minutes).

intec pharma ltd (INTP) Snapshot

Open
$59.50
Previous Close
$59.50
Day High
$60.50
Day Low
$58.70
52 Week High
03/31/14 - $92.00
52 Week Low
12/29/14 - $35.00
Market Cap
160.7M
Average Volume 10 Days
217.1K
EPS TTM
$-4.18
Shares Outstanding
270.0M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for INTEC PHARMA LTD (INTP)

Related News

No related news articles were found.

intec pharma ltd (INTP) Related Businessweek News

No Related Businessweek News Found

intec pharma ltd (INTP) Details

Intec Pharma Ltd., a drug development company, develops improved formulations of drugs using gastric retention technology. Its product portfolio includes Accordion Pill Carbidopa/Levodopa, a Phase II gastric-retentive dosage form for the treatment of Parkinson’s disease; and Accordion Pill – Zaleplon, a Phase II drug for treatment of insomnia. The company is based in Jerusalem, Israel.

intec pharma ltd (INTP) Top Compensated Officers

Chief Executive Officer and Director
Total Annual Compensation: --
Co-Founder and Chairman
Total Annual Compensation: 513.1K
Vice President of R&D & Operations
Total Annual Compensation: 474.6K
Compensation as of Fiscal Year 2013.

intec pharma ltd (INTP) Key Developments

Intec Pharma Ltd., Annual General Meeting, Mar 18, 2015

Intec Pharma Ltd., Annual General Meeting, Mar 18, 2015., at 11:00 Israel Standard Time.

US Food and Drug Administration Gives Phase III Nod for Intec Pharma Ltd.'s Parkinson Treatment

Intec Pharma Ltd. announced that it had received US Food and Drug Administration (FDA) approval for carrying out a Phase III trial of its Accordion Pill Levodopa for the treatment of Parkinson's Disease. The Accordion Pill is a gastro-retentive drug delivery system.

Intec Pharma Ltd. Presents at BIO-Europe 2014, Nov-05-2014 12:45 PM

Intec Pharma Ltd. Presents at BIO-Europe 2014, Nov-05-2014 12:45 PM. Venue: Portalhaus Messe Frankfurt, Strasse der Nationen, 60327 Frankfurt, Germany.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
INTP:IT 59.50 0.00

INTP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for INTP.
View Industry Companies
 

Industry Analysis

INTP

Industry Average

Valuation INTP Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact INTEC PHARMA LTD, please visit www.intecpharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.